Tag: USPTO

  • Patent Awarded for Early, Pre-Symptom Cancer Tests

    16 June 2015. Three researchers at Kansas State University in Manhattan received a patent for an early-stage test that the inventors say can diagnose some solid tumor cancers well before symptoms develop. Kansas State chemistry professor Stefan Bossmann and anatomy-physiology professor Deryl Troyer, with postdoctoral fellow Matthew Basel, received U.S. patent number 8,969,027 in March…

  • Patent Awarded for Plant Gene Sequence Engineering

    27 May 2015. A patent for a genetic sequence derived from soybeans, but applicable through engineering to a range of plants, was granted to Ceres Inc., an agricultural biotechnology company in Thousand Oaks, California. The U.S. Patent and Trademark Office granted patent number 9,024,004, Sequence-determined DNA fragments encoding acetohydroxyacid synthase proteins, on 5 May 2015 to…

  • Patent Issued for Mobile Pulse Oximetry Technology

    25 February 2015. LionsGate Technologies Inc., a medical device company in Vancouver, Canada, received a patent for techniques and processes that connect sensors measuring blood oxygen levels to smartphones and tablets. Patent number 8,958,859 was issued by U.S. Patent and Trademark Office on 17 February 2015 to inventors Mark Ansermino, LionsGate’s chief medical officer, and…

  • Patent Awarded for Neurostimulation Electronics

    17 February 2015. A U.S. patent on electronic components for switching and pulse generation in neurostimulation devices was awarded earlier this month. The Patent and Trademark Office awarded patent number 8,948,880 on 3 February to Barry Yomtov, founder and chief technologist of AdvaStim Inc. in Beverly, Massachusetts, and assigned to the company. AdvaStim develops modular…

  • Patent Awarded for Macular Degeneration Eyedrop Technology

    4 December 2014. SciFluor Life Sciences LLC, a biopharmaceutical company in Cambridge, Massachusetts received a patent on a fluoride formulation for treating diseases of the retina with eyedrops rather than injections into the eye as often required. Patent 8,901,144 was awarded on 2 December by the U.S. Patent and Trademark Office to four inventors, including…

  • Patent Awarded for Replacement Pancreas Cell Processes

    6 November 2014. ViaCyte Inc., a biotechnology company in San Diego, received a patent for its processes in making early stage pancreatic cells to replace defective cells in patients with type 1 diabetes. Patent number 8,859,286 was awarded in mid-October by U.S. Patent and Trademark Office to inventor Alan Agulnick, a researcher at ViaCyte, and…

  • Patent Issued for Engineered Peptides Forming Hydrogels

    4 November 2014. Bioengineers at Kansas State University received a patent for their invention of a peptide, a protein-like compound, that turns into water-based gels for a number of medical applications. U.S. Patent and Trademark Office awarded patent number 8,835,395 to Xiuzhi (Susan) Sun, professor of grain science and bioengineering at Kansas State, as well…

  • Patent Awarded for Detailed Pandemic Flu Detection Test

    8 October 2014. A genomics-based test to detect various types of pandemic influenza, including mutated forms resistant to antiviral drugs, is the recipient of a recent patent. The U.S. Patent and Trademark Office awarded patent number 8,808,993 — Methods and Kits to Detect New H1N1 “Swine Flu” Variants — to three inventors, and assigned it…

  • U.S. Patent Awarded for Freeze-Dried Vaccine Formulation

    9 September 2014. The technology making possible production and shipping of vaccines in a stable freeze-dried state received U.S. patent protection. Patent no. 8,808,710 was awarded last month by the U.S. Patent and Trademark Office to four inventors and assigned to University of Colorado. Soligenix Inc. in Princeton, New Jersey licensed the technology from University…

  • Arcadia Awarded U.S. Patent for Longer Shelf-Life Tomato

    17 July 2014. Arcadia Biosciences, an agricultural biotechnology company in Davis, California received a patent for its engineered tomato that ripens slower after harvesting. Patent number 8,772,606, “Non-transgenic tomato varieties having increased shelf life post-harvest,” was awarded by the U.S. Patent and Trademark Office on 8 July to two inventors and assigned to Arcadia Biosciences.…